Table 1.
Clinical characteristics of study participants.
| Donor ID | Age in Years | HIV-1 Status | History of an AIDS- defining illnessa | Use of HAARTb | Log10 viral load (copies/mL) | CD4 T cell count (cells/μL) |
|---|---|---|---|---|---|---|
| 1 | 41 | + | − | − | 4.0 | 845 |
| 2 | 48 | + | − | − | 3.4 | 493 |
| 3 | 62 | + | − | − | <1.7 | 679 |
| 4 | 76 | + | − | + | <1.7 | 1112 |
| 5 | 62 | + | − | + | <1.7 | 408 |
| 6 | 51 | + | − | + | <1.7 | 301 |
| 7 | 55 | + | + | − | 5.5 | 140 |
| 8 | 47 | + | + | − | 5.2 | 154 |
| 9 | 48 | + | + | − | 3.0 | 16 |
| 10 | 74 | − | NAc | NA | NA | 971 |
| 11 | 68 | − | NA | NA | NA | 911 |
| 12 | 55 | − | NA | NA | NA | 756 |
a
1993 CDC definition, excluding cases that were defined only by low CD4 T-cell count
b
Highly active antiretroviral therapy
c
Not applicable because donors are HIV-negative